首页 > 最新文献

Clinical research in infectious diseases最新文献

英文 中文
Guideline-concordant antibiotic prescribing for pediatric outpatients with otitis media, community-acquired pneumonia, and skin and soft tissue infections in a large multispecialty healthcare system. 大型多专科医疗保健系统中中耳炎、社区获得性肺炎、皮肤和软组织感染儿科门诊患者的抗生素处方指南一致性
Ezzeldin A Saleh, Darrell R Schroeder, Andrew C Hanson, Ritu Banerjee

Antibiotics are commonly prescribed in pediatric outpatient settings; however, efforts to decrease inappropriate use have largely focused on inpatients. We obtained baseline metrics to identify conditions that may benefit from establishment of outpatient antimicrobial stewardship interventions (ASP). We evaluated rates and appropriateness of antibiotic prescribing for children with acute otitis media (AOM), community acquired pneumonia (CAP), and skin and soft tissue infections (SSTI) in ambulatory settings within a large healthcare system in the US Midwest. We retrospectively reviewed 77,821 visits and associated diagnostic codes for children less than 17 years seen in ambulatory settings within our health system from August 1, 2009 to July 31, 2010. We measured rates of antibiotic prescribing by location, provider type, patient age, and diagnosis, and assessed concordance with treatment guidelines for AOM, CAP, and SSTI. AOM, CAP, and SSTI comprised about 1/3 of all infections in the study population. Antibiotics were prescribed in 14,543 (18.7%) visits. Antibiotic prescribing rates were 1.1 to 1.2 times higher among Emergency Room (ER) providers compared to Pediatricians and Family Physicians. Antibiotics prescribed for AOM and SSTI were concordant with guidelines in approximately 97% of cases. In contrast, 47% of antibiotics prescribed for treatment of CAP in children < 5 years old were macrolides, which are not recommended first line therapy for CAP in this age group. Antibiotic prescribing for pediatric outpatients within our health system is not guideline-concordant for treatment of CAP.

抗生素通常在儿科门诊开处方;然而,减少不适当使用的努力主要集中在住院病人身上。我们获得了基线指标,以确定可能从建立门诊抗菌药物管理干预措施(ASP)中受益的条件。我们评估了美国中西部一个大型医疗保健系统门诊环境中患有急性中耳炎(AOM)、社区获得性肺炎(CAP)和皮肤软组织感染(SSTI)的儿童抗生素处方的比率和适宜性。我们回顾性地回顾了2009年8月1日至2010年7月31日在我国卫生系统门诊就诊的17岁以下儿童的77,821次就诊和相关诊断代码。我们根据地点、提供者类型、患者年龄和诊断来测量抗生素处方率,并评估与AOM、CAP和SSTI治疗指南的一致性。AOM、CAP和SSTI约占研究人群中所有感染的三分之一。14543(18.7%)次就诊处方抗生素。与儿科医生和家庭医生相比,急诊室(ER)提供者的抗生素处方率高出1.1至1.2倍。在大约97%的病例中,AOM和SSTI的抗生素处方与指南一致。相比之下,在5岁以下儿童中,47%用于治疗CAP的抗生素是大环内酯类药物,不建议在该年龄组中使用大环内酯类药物作为CAP的一线治疗药物。在我们的卫生系统中,儿科门诊患者的抗生素处方与治疗CAP的指南不一致。
{"title":"Guideline-concordant antibiotic prescribing for pediatric outpatients with otitis media, community-acquired pneumonia, and skin and soft tissue infections in a large multispecialty healthcare system.","authors":"Ezzeldin A Saleh,&nbsp;Darrell R Schroeder,&nbsp;Andrew C Hanson,&nbsp;Ritu Banerjee","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Antibiotics are commonly prescribed in pediatric outpatient settings; however, efforts to decrease inappropriate use have largely focused on inpatients. We obtained baseline metrics to identify conditions that may benefit from establishment of outpatient antimicrobial stewardship interventions (ASP). We evaluated rates and appropriateness of antibiotic prescribing for children with acute otitis media (AOM), community acquired pneumonia (CAP), and skin and soft tissue infections (SSTI) in ambulatory settings within a large healthcare system in the US Midwest. We retrospectively reviewed 77,821 visits and associated diagnostic codes for children less than 17 years seen in ambulatory settings within our health system from August 1, 2009 to July 31, 2010. We measured rates of antibiotic prescribing by location, provider type, patient age, and diagnosis, and assessed concordance with treatment guidelines for AOM, CAP, and SSTI. AOM, CAP, and SSTI comprised about 1/3 of all infections in the study population. Antibiotics were prescribed in 14,543 (18.7%) visits. Antibiotic prescribing rates were 1.1 to 1.2 times higher among Emergency Room (ER) providers compared to Pediatricians and Family Physicians. Antibiotics prescribed for AOM and SSTI were concordant with guidelines in approximately 97% of cases. In contrast, 47% of antibiotics prescribed for treatment of CAP in children < 5 years old were macrolides, which are not recommended first line therapy for CAP in this age group. Antibiotic prescribing for pediatric outpatients within our health system is not guideline-concordant for treatment of CAP.</p>","PeriodicalId":72628,"journal":{"name":"Clinical research in infectious diseases","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2015-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394205/pdf/nihms668884.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33221884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender Differences in Non-Toxigenic Clostridium difficile Colonization and Risk of Subsequent C. difficile Infection. 非产毒性艰难梭菌定植的性别差异和随后艰难梭菌感染的风险。
Mukil Natarajan, Mary Am Rogers, Jacob Bundy, Dejan Micic, Seth T Walk, Kavitha Santhosh, Krishna Rao, Spencer Winters, Vincent B Young, David M Aronoff

Objectives: Previous studies suggest that colonization with non-toxigenic Clostridium difficile may protect against toxigenic C. difficile infection (CDI), yet most of the studies were conducted in men. Therefore, we conducted a study to examine this hypothesis in both genders.

Methods: Patients (n=1492) were classified by disease status at baseline and observed for 1 year. Cox proportional hazards regression was used to evaluate CDI rates within 8 weeks post-baseline (short-term) and from 8 weeks to 1 year (long-term follow-up).

Results: During short-term follow-up, CDI rates were 5 times greater in females with non-toxigenic Clostridium difficile compared to females without C. difficile (hazard ratio (HR) = 5.13; 95% CI: 1.47-17.83). The comparable HR in males was 0.44 (95% CI: 0.04-4.43). During long term follow-up, CDI rates were similar in those with non-toxigenic C. difficile and those without C. difficile at baseline, for both females and males. Mortality rates were significantly lower for patients colonized by non-toxigenic C. difficile than those with toxigenic C. difficile at baseline, for both genders combined (HR=0.51; 95% CI: 0.28-0.92) and were similar to those with no C. difficile at baseline (HR=0.78; 95% CI: 0.43-1.41).

Conclusions: There were gender differences in the short-term risk of CDI. Mortality was similar for patients colonized with non-toxigenic C. difficile and patients without C. difficile.

目的:先前的研究表明,非产毒性艰难梭菌定殖可预防产毒性艰难梭菌感染(CDI),但大多数研究都是在男性中进行的。因此,我们进行了一项研究,在两性中检验这一假设。方法:1492例患者在基线时按疾病状态分类,观察1年。采用Cox比例风险回归评估基线后8周(短期)和8周至1年(长期随访)的CDI发生率。结果:在短期随访中,携带非产毒艰难梭菌的女性的CDI发生率是未携带艰难梭菌的女性的5倍(风险比(HR) = 5.13;95% ci: 1.47-17.83)。男性的可比HR为0.44 (95% CI: 0.04-4.43)。在长期随访中,在基线时,无论是女性还是男性,非产毒性艰难梭菌患者和无艰难梭菌患者的CDI率相似。在基线时,非产毒艰难梭菌定殖的患者死亡率显著低于产毒艰难梭菌定殖的患者(HR=0.51;95% CI: 0.28-0.92),与基线时无艰难梭菌的患者相似(HR=0.78;95% ci: 0.43-1.41)。结论:CDI的短期风险存在性别差异。非产毒艰难梭菌定殖患者和无艰难梭菌定殖患者的死亡率相似。
{"title":"Gender Differences in Non-Toxigenic <i>Clostridium difficile</i> Colonization and Risk of Subsequent <i>C. difficile Infection</i>.","authors":"Mukil Natarajan,&nbsp;Mary Am Rogers,&nbsp;Jacob Bundy,&nbsp;Dejan Micic,&nbsp;Seth T Walk,&nbsp;Kavitha Santhosh,&nbsp;Krishna Rao,&nbsp;Spencer Winters,&nbsp;Vincent B Young,&nbsp;David M Aronoff","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>Previous studies suggest that colonization with non-toxigenic <i>Clostridium difficile</i> may protect against toxigenic <i>C. difficile</i> infection (CDI), yet most of the studies were conducted in men. Therefore, we conducted a study to examine this hypothesis in both genders.</p><p><strong>Methods: </strong>Patients (n=1492) were classified by disease status at baseline and observed for 1 year. Cox proportional hazards regression was used to evaluate CDI rates within 8 weeks post-baseline (short-term) and from 8 weeks to 1 year (long-term follow-up).</p><p><strong>Results: </strong>During short-term follow-up, CDI rates were 5 times greater in females with non-toxigenic <i>Clostridium difficile</i> compared to females without <i>C. difficile</i> (hazard ratio (HR) = 5.13; 95% CI: 1.47-17.83). The comparable HR in males was 0.44 (95% CI: 0.04-4.43). During long term follow-up, CDI rates were similar in those with non-toxigenic <i>C. difficile</i> and those without <i>C. difficile</i> at baseline, for both females and males. Mortality rates were significantly lower for patients colonized by non-toxigenic <i>C. difficile</i> than those with toxigenic <i>C. difficile</i> at baseline, for both genders combined (HR=0.51; 95% CI: 0.28-0.92) and were similar to those with no <i>C. difficile</i> at baseline (HR=0.78; 95% CI: 0.43-1.41).</p><p><strong>Conclusions: </strong>There were gender differences in the short-term risk of CDI. Mortality was similar for patients colonized with non-toxigenic <i>C. difficile</i> and patients without <i>C. difficile</i>.</p>","PeriodicalId":72628,"journal":{"name":"Clinical research in infectious diseases","volume":"2 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508598/pdf/nihms871535.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9942966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical research in infectious diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1